Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03431363 · ClinicalTrials.gov registry record
Medical Cannabis During Chemoradiation for Head and Neck Cancer
A clinical trial, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- 30
- Enrollment target
NCT03431363 is a clinical trial that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 30 participants.
The verdict
NCT03431363 has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The primary purpose of the study is to observe the adherence and health seeking behavior of patients with Head and Neck cancer (HNC) certified to obtain medically certified cannabis as part of their supportive care regimen undergoing treatment with definitive or adjuvant concurrent chemoradiation (CRT).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2026-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03431363
The ClinicalTrials.gov registry entry for NCT03431363 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03431363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03431363 about?
NCT03431363 is a clinical study titled "Medical Cannabis During Chemoradiation for Head and Neck Cancer". The primary purpose of the study is to observe the adherence and health seeking behavior of patients with Head and Neck cancer (HNC) certified to obtain medically certified cannabis as part of their supportive care regimen undergoing treatment with definitive or adjuvant concurrent chemoradiation (C...
What is the current status of trial NCT03431363?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-05-18. Estimated completion is 2026-01-14.
Who is sponsoring clinical trial NCT03431363?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.